Prediction Case File
YouTubePartially Resolved

Join the $1K to $100K Trading Challenge! - https://bit.ly/1kto100ktradingchallenge

2 extracted signals · 1 resolved · 1 still active

Altcoin Doctor profile imageAltcoin Doctor09 Sept 2025, 19:20 UTC
Video preview for Join the $1K to $100K Trading Challenge! - https://bit.ly/1kto100ktradingchallenge
Signals
2
Eligible signals in this source
Open
1
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis predicts an altcoin season. DOTUSDT is analyzed on the weekly timeframe using Fibonacci retracement. The target price is around $38, a 700% increase, with a failure bound at $3.6953. The USDT dominance chart is expected to decline to around 2%, suggesting a bullish trend. Bitcoin dominance is expected to fall, with a target around 35%, failing the prediction over 75.95. Total crypto market cap is expected to reach 5.62T, indicating a bullish trend.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    2 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Altcoin Doctor

Tracked signals
940
Historical success
14.8%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.